Evidence exhibits that insufficient or low well being literacy (LHL) ranges are considerably related to financial ramifications at the particular person, employer, and well being care system ranges. Therefore, this examine goals to estimate the financial burden of LHL amongst a culturally and linguistically numerous (CALD) group in Blacktown: a neighborhood authorities space (LGA) in Sydney, Australia.

This examine is a secondary evaluation of cross-sectional information from publicly accessible datasets, together with 2011 and 2016 census information and National Health Survey (NHS) information (2017-2018) from the Australian Bureau of Statistics (ABS), and figures on Disease Expenditure in Australia for 2015-2016 offered by the Australian Institute of Health and Welfare (AIHW).

This examine discovered that 20% of Blacktown residents reported low ranges of energetic engagement with well being care suppliers (Domain 6 of the Health Literacy Questionnaire (HLQ)), with 14% reporting a restricted understanding of the well being info required to take motion in direction of enhancing well being or making well being care choices (Domain 9 of the HLQ).

The general further/delta price (direct and oblique well being care prices) related to LHL in the Blacktown LGA was estimated to be between $11,785,528 and $15,432,239 in 2020. This is projected to extend to between $18,922,844 and $24,191,911 in 2030. Additionally, the further disability-adjusted life yr (DALY) worth in 2020, for all power ailments and age-groups-comprising the further prices incurred as a consequence of years of life misplaced (YLL) and years lived with incapacity (YLD)-was estimated at $414,231,335. The findings of our examine might allow policymakers to have a deeper understanding of the financial burden of LHL in phrases of its affect on the well being care system and the manufacturing economic system.

Lung Tissue Lysate (Normal)
1701-03	ProSci	0.1 mg	EUR 260.7
Description: Lung tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Lung Tissue Lysate (Normal)
1701-04	ProSci	0.1 mg	EUR 260.7
Description: Lung tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Lung Tissue Lysate (Normal)
1701-05	ProSci	0.1 mg	EUR 260.7
Description: Lung tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Monkey (Cyno.) Normal Lung Whole tissue lysate
MCL-1194	Alpha Diagnostics	1 mg	EUR 628.8

Tissue Lysate (Normal) Human Heart
GWB-54C253	GenWay Biotech	0.15 mg	Ask for price

Human Tissue Lysate (Normal) Human Stomach
GWB-3BB116	GenWay Biotech	0.15 mg	Ask for price

Tissue Lysate (Normal) Human Kidney
GWB-FEAC28	GenWay Biotech	0.15 mg	Ask for price

Human Tissue Lysate (Normal) Human Pancreas
GWB-8C6670	GenWay Biotech	0.15 mg	Ask for price

Human Tissue Lysate (Normal) Human Prostate
GWB-326D8C	GenWay Biotech	0.15 mg	Ask for price

Monkey (Rhesus) Normal Lung Whole tissue lysate
MRL-1305	Alpha Diagnostics	1 mg	EUR 628.8

cDNA – Human Adult Normal Tissue: Lung
C1234152	Biochain	40 reactions	EUR 311.5

Human Adult Eye whole (Normal) tissue lysate
HAL-1385	Alpha Diagnostics	100 ug	EUR 285.6

Human Adult Skin (Normal) Whole tissue lysate
HAL-1376	Alpha Diagnostics	1 mg	EUR 628.8

Human Adult Heart (Normal) Whole tissue lysate
HAL-1301	Alpha Diagnostics	1 mg	EUR 628.8

Human Adult Brain (Normal) Whole tissue lysate
HAL-1303	Alpha Diagnostics	1 mg	EUR 628.8

Human Adult Liver (Normal) Whole tissue lysate
HAL-1304	Alpha Diagnostics	1 mg	EUR 628.8

Human Adult Ovary (Normal) Whole tissue lysate
HAL-1316	Alpha Diagnostics	1 mg	EUR 628.8

Human Adult Colon (Normal) Whole tissue lysate
HAL-1320	Alpha Diagnostics	1 mg	EUR 628.8

Human Adult Kidney (Normal) Whole tissue lysate
HAL-1305	Alpha Diagnostics	1 mg	EUR 628.8

Human Adult Spleen (Normal) Whole tissue lysate
HAL-1306	Alpha Diagnostics	1 mg	EUR 628.8

Human Adult Breast (Normal) Whole tissue lysate
HAL-1311	Alpha Diagnostics	1 mg	EUR 628.8

Human Adult Testis (Normal) Whole tissue lysate
HAL-1313	Alpha Diagnostics	1 mg	EUR 628.8

Human Adult Thymus (Normal) Whole tissue lysate
HAL-1314	Alpha Diagnostics	1 mg	EUR 628.8

Human Adult Tonsil (Normal) Whole tissue lysate
HAL-1315	Alpha Diagnostics	1 mg	EUR 628.8

Human Adult Uterus (Normal) Whole tissue lysate
HAL-1317	Alpha Diagnostics	1 mg	EUR 628.8

Human Adult Rectum (Normal) Whole tissue lysate
HAL-1373	Alpha Diagnostics	1 mg	EUR 628.8

Human Adult Retina (Normal) Whole tissue lysate
HAL-1374	Alpha Diagnostics	1 mg	EUR 628.8

Human Adult Bladder (Normal) Whole tissue lysate
HAL-1310	Alpha Diagnostics	1 mg	EUR 628.8

Human Adult Stomach (Normal) Whole tissue lysate
HAL-1319	Alpha Diagnostics	1 mg	EUR 628.8

Human Adult Thyroid (Normal) Whole tissue lysate
HAL-1380	Alpha Diagnostics	1 mg	EUR 628.8

Human Normal Adrenal Gland Whole tissue lysate
HALX-11050	Alpha Diagnostics	1 mg	EUR 927.6

Human Adult Pancreas (Normal) Whole tissue lysate
HAL-1307	Alpha Diagnostics	1 mg	EUR 628.8

Human Adult Placenta (Normal) Whole tissue lysate
HAL-1309	Alpha Diagnostics	1 mg	EUR 628.8

Human Adult Prostate (Normal) Whole tissue lysate
HAL-1312	Alpha Diagnostics	1 mg	EUR 628.8

Human Adult Appendix (Normal) Whole tissue lysate
HAL-1361	Alpha Diagnostics	1 mg	EUR 628.8

Human Pituitary Gland (Normal) Whole tissue lysate
HALX-10141	Alpha Diagnostics	100ug	EUR 416.4

Tissue, Total Protein, Human Adult Normal, Lung
MBS657306-1mg	MyBiosource	1mg	EUR 565

Tissue, Total Protein, Human Adult Normal, Lung
MBS657306-5x1mg	MyBiosource	5x1mg	EUR 2315

Human Lung Tissue Lysate
MBS537538-015mg	MyBiosource	0.15mg	EUR 410

Human Lung Tissue Lysate
MBS537538-5x015mg	MyBiosource	5×0.15mg	EUR 1625

Human Lung Tissue Preparation Buffer 1: Normal Lung Fibroblasts
9-80081	CHI Scientific	1 x 100 ml	EUR 280.9

Tissue, Section, Human Adult Normal, Lung (Frozen)
MBS640219-5Sections	MyBiosource	5Sections	EUR 635

Tissue, Section, Human Adult Normal, Lung (Frozen)
MBS640219-5x5Sections	MyBiosource	5x5Sections	EUR 2640

Tissue, Section, Human Adult Normal, Lung (Paraffin)
MBS640360-5Sections	MyBiosource	5Sections	EUR 460

Tissue, Section, Human Adult Normal, Lung (Paraffin)
MBS640360-5x5Sections	MyBiosource	5x5Sections	EUR 1925

Tissue, Membrane Protein, Human Adult Normal, Lung
MBS639788-01mg	MyBiosource	0.1mg	EUR 570

Tissue, Membrane Protein, Human Adult Normal, Lung
MBS639788-5x01mg	MyBiosource	5×0.1mg	EUR 2345

Human Adult Lymph Node (Normal) Whole tissue lysate
HAL-1369	Alpha Diagnostics	1 mg	EUR 927.6

Human Adult Spinal Cord (Normal) Whole tissue lysate
HAL-1377	Alpha Diagnostics	1 mg	EUR 927.6

FFPE Total RNA – Human Adult Normal Tissue: Lung
R2234152	Biochain	1 ug	EUR 744

Human Adult Salivary (Normal) Gland Whole tissue lysate
HAL-20103	Alpha Diagnostics	1 mg	EUR 927.6

Tissue, Universal Protein Lysate, Human Adult Normal
MBS657504-2x05mg	MyBiosource	2×0.5mg	EUR 605

Tissue, Universal Protein Lysate, Human Adult Normal
MBS657504-4x05mg	MyBiosource	4×0.5mg	EUR 795

FFPE Genomic DNA – Human Adult Normal Tissue: Lung
D2234152	Biochain	2 ug	EUR 578.2

Human Adult Small Intestine (Normal) Whole tissue lysate
HAL-1308	Alpha Diagnostics	1 mg	EUR 628.8

Human Adult Skeletal Muscle (Normal) Whole tissue lysate
HAL-1375	Alpha Diagnostics	1 mg	EUR 628.8

Tissue, Total RNA, Human Adult Normal, Lung, BioGenomics
MBS638762-005mg	MyBiosource	0.05mg	EUR 495

Tissue, Total RNA, Human Adult Normal, Lung, BioGenomics
MBS638762-5x005mg	MyBiosource	5×0.05mg	EUR 1995

Tissue, Total Protein, Human Adult Normal, Lung, Trachea
MBS657162-1mg	MyBiosource	1mg	EUR 565

Tissue, Total Protein, Human Adult Normal, Lung, Trachea
MBS657162-5x1mg	MyBiosource	5x1mg	EUR 2315

Human Lung Fetal Tissue Lysate
IHULGFSTL100UG	Innovative research	each	EUR 541
Description: Human Lung Fetal Tissue Lysate

Human Lung Fetal Tissue Lysate
MBS8414461-01mg	MyBiosource	0.1mg	EUR 745

Human Lung Fetal Tissue Lysate
MBS8414461-5x01mg	MyBiosource	5×0.1mg	EUR 3165

Tissue, Section, Human Adult Normal, Lung, Trachea (Frozen)
MBS640092-5Sections	MyBiosource	5Sections	EUR 635

Tissue, Section, Human Adult Normal, Lung, Trachea (Frozen)
MBS640092-5x5Sections	MyBiosource	5x5Sections	EUR 2640

Colon Tissue Lysate (Normal)
1715-01	ProSci	0.1 mg	EUR 260.7
Description: Colon tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Colon Tissue Lysate (Normal)
1715-02	ProSci	0.1 mg	EUR 260.7
Description: Colon tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Colon Tissue Lysate (Normal)
1715-03	ProSci	0.1 mg	EUR 260.7
Description: Colon tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Colon Tissue Lysate (Normal)
1715-04	ProSci	0.1 mg	EUR 260.7
Description: Colon tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Colon Tissue Lysate (Normal)
1715-05	ProSci	0.1 mg	EUR 260.7
Description: Colon tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Colon Tissue Lysate (Normal)
1715-06	ProSci	0.1 mg	EUR 260.7
Description: Colon tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Colon Tissue Lysate (Normal)
1715-07	ProSci	0.1 mg	EUR 260.7
Description: Colon tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Colon Tissue Lysate (Normal)
1715-08	ProSci	0.1 mg	EUR 260.7
Description: Colon tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Colon Tissue Lysate (Normal)
1715-10	ProSci	0.1 mg	EUR 260.7
Description: Colon tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Colon Tissue Lysate (Normal)
1715-11	ProSci	0.1 mg	EUR 260.7
Description: Colon tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Colon Tissue Lysate (Normal)
1715-12	ProSci	0.1 mg	EUR 260.7
Description: Colon tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Colon Tissue Lysate (Normal)
1715-13	ProSci	0.1 mg	EUR 260.7
Description: Colon tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Colon Tissue Lysate (Normal)
1715-14	ProSci	0.1 mg	EUR 260.7
Description: Colon tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Colon Tissue Lysate (Normal)
1715-15	ProSci	0.1 mg	EUR 260.7
Description: Colon tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Colon Tissue Lysate (Normal)
1715-16	ProSci	0.1 mg	EUR 260.7
Description: Colon tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Colon Tissue Lysate (Normal)
1715-17	ProSci	0.1 mg	EUR 260.7
Description: Colon tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Colon Tissue Lysate (Normal)
1715-19	ProSci	0.1 mg	EUR 260.7
Description: Colon tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Colon Tissue Lysate (Normal)
1715-20	ProSci	0.1 mg	EUR 260.7
Description: Colon tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Colon Tissue Lysate (Normal)
1715-21	ProSci	0.1 mg	EUR 260.7
Description: Colon tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Colon Tissue Lysate (Normal)
1715-22	ProSci	0.1 mg	EUR 260.7
Description: Colon tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Liver Tissue Lysate (Normal)
1718-01	ProSci	0.1 mg	EUR 260.7
Description: Liver tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Liver Tissue Lysate (Normal)
1718-02	ProSci	0.1 mg	EUR 260.7
Description: Liver tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Brain Tissue Lysate (Normal)
1731-01	ProSci	0.1 mg	EUR 260.7
Description: Brain tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Brain Tissue Lysate (Normal)
1731-02	ProSci	0.1 mg	EUR 260.7
Description: Brain tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Brain Tissue Lysate (Normal)
1731-03	ProSci	0.1 mg	EUR 260.7
Description: Brain tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Tissue, Genomic DNA, Human Adult Normal, Lung, BioGenomics
MBS654510-01mg	MyBiosource	0.1mg	EUR 575

Tissue, Genomic DNA, Human Adult Normal, Lung, BioGenomics
MBS654510-5x01mg	MyBiosource	5×0.1mg	EUR 2440

Human Lupus Lung Tissue Lysate
IHULGLUPPTL100UG	Innovative research	each	EUR 1413
Description: Human Lupus Lung Tissue Lysate

Human Lupus Lung Tissue Lysate
MBS8414467-01mg	MyBiosource	0.1mg	EUR 1810

Human Lupus Lung Tissue Lysate
MBS8414467-5x01mg	MyBiosource	5×0.1mg	EUR 7965

cDNA – Human Adult Normal Tissue: Lung: Left Lower Lobe
C1234155	Biochain	40 reactions	EUR 311.5

cDNA – Human Adult Normal Tissue: Lung: Left Upper Lobe
C1234156	Biochain	40 reactions	EUR 311.5

Kidney Tissue Lysate (Normal)
1706-04	ProSci	0.1 mg	EUR 260.7
Description: Kidney tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Kidney Tissue Lysate (Normal)
1706-05	ProSci	0.1 mg	EUR 260.7
Description: Kidney tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Breast Tissue Lysate (Normal)
1710-01	ProSci	0.1 mg	EUR 260.7
Description: Breast tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Breast Tissue Lysate (Normal)
1710-03	ProSci	0.1 mg	EUR 260.7
Description: Breast tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Breast Tissue Lysate (Normal)
1710-04	ProSci	0.1 mg	EUR 260.7
Description: Breast tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Breast Tissue Lysate (Normal)
1710-05	ProSci	0.1 mg	EUR 260.7
Description: Breast tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Breast Tissue Lysate (Normal)
1710-06	ProSci	0.1 mg	EUR 260.7
Description: Breast tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Breast Tissue Lysate (Normal)
1710-07	ProSci	0.1 mg	EUR 260.7
Description: Breast tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Breast Tissue Lysate (Normal)
1710-08	ProSci	0.1 mg	EUR 260.7
Description: Breast tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Breast Tissue Lysate (Normal)
1710-10	ProSci	0.1 mg	EUR 260.7
Description: Breast tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Breast Tissue Lysate (Normal)
1710-11	ProSci	0.1 mg	EUR 260.7
Description: Breast tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Breast Tissue Lysate (Normal)
1710-12	ProSci	0.1 mg	EUR 260.7
Description: Breast tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Cervix Tissue Lysate (Normal)
1746-01	ProSci	0.1 mg	EUR 260.7
Description: Cervix tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Cervix Tissue Lysate (Normal)
1746-02	ProSci	0.1 mg	EUR 260.7
Description: Cervix tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Cervix Tissue Lysate (Normal)
1746-03	ProSci	0.1 mg	EUR 260.7
Description: Cervix tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Kidney Tissue Lysate (Normal)
1706-02	ProSci	0.1 mg	EUR 260.7
Description: Kidney tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Kidney Tissue Lysate (Normal)
1706-03	ProSci	0.1 mg	EUR 260.7
Description: Kidney tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Tissue, Membrane Protein, Human Adult Normal, Lung, Trachea
MBS639821-01mg	MyBiosource	0.1mg	EUR 570

Tissue, Membrane Protein, Human Adult Normal, Lung, Trachea
MBS639821-5x01mg	MyBiosource	5×0.1mg	EUR 2345

Stomach Tissue Lysate (Normal)
1717-01	ProSci	0.1 mg	EUR 260.7
Description: Stomach tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Bladder Tissue Lysate (Normal)
1721-01	ProSci	0.1 mg	EUR 260.7
Description: Bladder tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

cDNA – Human Adult Normal Tissue: Lung: Right Lower Lobe
C1234157	Biochain	40 reactions	EUR 311.5

cDNA – Human Adult Normal Tissue: Lung: Right Upper Lobe
C1234159	Biochain	40 reactions	EUR 311.5

Pancreas Tissue Lysate (Normal)
1736-02	ProSci	0.1 mg	EUR 260.7
Description: Pancreas tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Pancreas Tissue Lysate (Normal)
1736-05	ProSci	0.1 mg	EUR 260.7
Description: Pancreas tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

cDNA – Human Adult Normal Tissue: Lung: Right Middle Lobe
C1234158	Biochain	40 reactions	EUR 311.5

Human Diabetes Lung Tissue Lysate
IHULGDIBTL100UG	Innovative research	each	EUR 1413
Description: Human Diabetes Lung Tissue Lysate

Human Diabetes Lung Tissue Lysate
MBS8414460-01mg	MyBiosource	0.1mg	EUR 1810

Human Diabetes Lung Tissue Lysate
MBS8414460-5x01mg	MyBiosource	5×0.1mg	EUR 7965

Lung Tissue Slide (Normal)
10-101-10um	ProSci	10 um	EUR 241.8

Lung Tissue Slide (Normal)
10-101-4um	ProSci	4 um	EUR 216.6

Normal lung tissue array
LC725	TissueArray	each	EUR 270
Description: Normal lung tissue array, 24 cases/72 cores, replacing BN04011

Normal lung tissue array
LCN241	TissueArray	each	EUR 114
Description: Normal lung tissue array, 24 cases/24 cores

Lung Tissue Slide (Normal)
MBS154259-10um	MyBiosource	10um	EUR 210

Lung Tissue Slide (Normal)
MBS154259-4um	MyBiosource	4um	EUR 195

Lung Tissue Slide (Normal)
MBS154259-5x10um	MyBiosource	5x10um	EUR 920

Human WI-38 (Lung Fibroblast, normal) lysate
HCL-1226	Alpha Diagnostics	100ug	EUR 285.6

Lung Tissue Slides, Normal Human Paraffin Sections, 5 slides/pack
TS-H5015	IHC World	–	EUR 145

Tissue cDNA, First Strand, Human Adult Normal, Lung, BioGenomics
MBS652185-40Tests	MyBiosource	40Tests	EUR 680

Tissue cDNA, First Strand, Human Adult Normal, Lung, BioGenomics
MBS652185-5x40Tests	MyBiosource	5x40Tests	EUR 2835

Lung cancer tissue array with adjacent normal lung tissue
LC813a	TissueArray	each	EUR 270
Description: Lung cancer tissue array with adjacent normal lung tissue, including TNM, clinical stage and pathology grade, 78 cases/80 cores, replaced by LC813b

Liver Tissue Lysate Normal Rabbit
GWB-369DB5	GenWay Biotech	0.15 mg	Ask for price

Matched Pair – DNA – Human Primary Tumor and Normal Tissue: Lung
D8235152-PP-10	Biochain	2×10 ug	EUR 334.6

Tissue Set, BioAssay, DNA, RNA, Protein, Human Adult Normal, Lung
MBS639634-1Kit	MyBiosource	1Kit	EUR 730

Tissue Set, BioAssay, DNA, RNA, Protein, Human Adult Normal, Lung
MBS639634-5x1Kit	MyBiosource	5x1Kit	EUR 3075

Lung cancer and normal lung tissue array
LC482	TissueArray	each	EUR 198
Description: Lung cancer and normal lung tissue array, including TNM, clinical stage and pathology grade, 24 cases/48 cores

Lung cancer and normal lung tissue array
LC811a	TissueArray	each	EUR 270
Description: Lung cancer and normal lung tissue array, including pathology grade, TNM and clinical stage, 80 cases/80 core

Matched Pair – cDNA – Human Primary Tumor and Normal Tissue: Lung
C8235152-PP	Biochain	10 reactions x2	EUR 408.1

Tissue, Total Protein, Human Adult Normal, Lung, Left Upper Lobe
MBS657311-1mg	MyBiosource	1mg	EUR 565

Tissue, Total Protein, Human Adult Normal, Lung, Left Upper Lobe
MBS657311-5x1mg	MyBiosource	5x1mg	EUR 2315

Tissue, Total Protein, Human Adult Normal, Lung, Left Lower Lobe
MBS657458-1mg	MyBiosource	1mg	EUR 565

Tissue, Total Protein, Human Adult Normal, Lung, Left Lower Lobe
MBS657458-5x1mg	MyBiosource	5x1mg	EUR 2315

cDNA – Rat Normal Tissue: Lung
C1434152	Biochain	40 reactions	EUR 311.5

cDNA – Dog Normal Tissue: Lung
C1734152	Biochain	40 reactions	EUR 311.5

Tissue, Total Protein, Human Adult Normal, Lung, Right Upper Lobe
MBS657228-1mg	MyBiosource	1mg	EUR 565

Tissue, Total Protein, Human Adult Normal, Lung, Right Upper Lobe
MBS657228-5x1mg	MyBiosource	5x1mg	EUR 2315

Tissue, Total Protein, Human Adult Normal, Lung, Right Lower Lobe
MBS657273-1mg	MyBiosource	1mg	EUR 565

Tissue, Total Protein, Human Adult Normal, Lung, Right Lower Lobe
MBS657273-5x1mg	MyBiosource	5x1mg	EUR 2315

Tissue, Total Protein, Human Adult Normal, Lung, Right Middle Lobe
MBS657534-1mg	MyBiosource	1mg	EUR 565

Tissue, Total Protein, Human Adult Normal, Lung, Right Middle Lobe
MBS657534-5x1mg	MyBiosource	5x1mg	EUR 2315

cDNA – Mouse Normal Tissue: Lung
C1334152	Biochain	40 reactions	EUR 311.5

Human Liver Cirrhosis Lung Tissue Lysate
IHULGCIRTL100UG	Innovative research	each	EUR 1413
Description: Human Liver Cirrhosis Lung Tissue Lysate

Human Liver Cirrhosis Lung Tissue Lysate
MBS8414459-01mg	MyBiosource	0.1mg	EUR 1810

Human Liver Cirrhosis Lung Tissue Lysate
MBS8414459-5x01mg	MyBiosource	5×0.1mg	EUR 7965

Tissue, Membrane Protein, Human Adult Normal, Lung, Left Upper Lobe
MBS639903-01mg	MyBiosource	0.1mg	EUR 570

Tissue, Membrane Protein, Human Adult Normal, Lung, Left Upper Lobe
MBS639903-5x01mg	MyBiosource	5×0.1mg	EUR 2345

Normal lung tissue with liver tissue array
LCN981	TissueArray	each	EUR 354
Description: Normal lung tissue with liver tissue array, 49 cases/98 cores (1.5mm)

Rat Tissue Lysate Normal Eye Retina
GWB-792900	GenWay Biotech	0.15 mg	Ask for price

Genomic DNA – Human Adult Normal Tissue: Lung, from a single donor
D1234152	Biochain	100 ug	EUR 241.5

Tissue cDNA, First Strand, Human Adult Normal, Lung, Trachea, BioGenomics
MBS652253-10Tests	MyBiosource	10Tests	EUR 540

Tissue cDNA, First Strand, Human Adult Normal, Lung, Trachea, BioGenomics
MBS652253-5x10Tests	MyBiosource	5x10Tests	EUR 2215

Lung tuberculosis tissue array with normal tissue
LC1007	TissueArray	each	EUR 306
Description: Lung tuberculosis tissue array with normal tissue, 48 cases/100 cores

Tissue, Total RNA, Human Adult Normal, Lung, Left Lower Lobe, BioGenomics
MBS638567-005mg	MyBiosource	0.05mg	EUR 495

Tissue, Total RNA, Human Adult Normal, Lung, Left Lower Lobe, BioGenomics
MBS638567-5x005mg	MyBiosource	5×0.05mg	EUR 1995

Rat normal lung test tissue array
TR041	TissueArray	each	EUR 48
Description: Rat normal lung test tissue array, 6 cases/24 cores

Human Lung Tissue Preparation Buffer 3: Normal Pulmonary Artery Fibroblasts
9-80083	CHI Scientific	1 x 100 ml	EUR 160.65

Tissue, Total RNA, Human Adult Normal, Lung, Right Middle Lobe, BioGenomics
MBS638624-005mg	MyBiosource	0.05mg	EUR 495

Tissue, Total RNA, Human Adult Normal, Lung, Right Middle Lobe, BioGenomics
MBS638624-5x005mg	MyBiosource	5×0.05mg	EUR 1995

Tissue, Total Protein, Matched Pairs, Human Primary Tumor and Normal, Lung
MBS657513-2x02mg	MyBiosource	2×0.2mg	EUR 935

Matched Pair (Normal and Carcinoma) Human Lung Tissue Array (5 slides/pk)
TAS-1002	Alpha Diagnostics	1 pk	EUR 343.2

Genomic DNA – Rat Normal Tissue: Lung
D1434152	Biochain	100 ug	EUR 241.5

Rat Tissue Lysate Kidney Medulla Normal
GWB-F5DEBF	GenWay Biotech	0.15 mg	Ask for price

Tissue, Section, Matched Pairs, Human Primary Tumor and Normal, Lung, Frozen
MBS640721-2x5Sections	MyBiosource	2x5Sections	EUR 900

Lung cancer and normal tissue array
LC722	TissueArray	each	EUR 306
Description: Lung cancer and normal tissue array, with TNM and grade data, 24 cases/72 cores